相关实验视频
Updated: Jun 27, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
黑色素瘤治疗的现状和下一步:打击治疗阻力
Anna Fateeva1,2, Kevinn Eddy1,2, Suzie Chen1,2,3,4
1Susan Lehman Cullman Laboratory for Cancer Research, Rutgers University, Piscataway, NJ 08854, USA.
Cancers
|April 27, 2024
概括
针对性疗法和免疫疗法等黑色素瘤治疗方法有希望,但却面临阻力. 了解耐药机制是改善黑色素瘤治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 黑色素瘤是一种具有高转移潜力的侵袭性皮肤癌.
- 针对性治疗和免疫疗法的进步改善了黑色素瘤治疗结果.
- 治疗耐药性,无论是获得的还是内在的,都限制了治疗的有效性.
研究的目的:
- 审查当前的黑色素瘤治疗选择.
- 探索驱动黑色素瘤治疗耐药性的机制.
- 为了解决克服阻力策略的发展提供信息.
主要方法:
- 关于黑色素瘤治疗药物的文献综述.
- 分析治疗耐药性背后的机制.
- 综合当前关于黑色素瘤治疗耐药性的知识.
主要成果:
- 目前的黑色素瘤疗法包括向药物和免疫疗法.
- 耐药性的机制包括遗传突变,表观遗传改变和瘤微环境因素.
- 无论是获得的还是内在的耐药性都会显著阻碍治疗的成功.
结论:
- 克服治疗耐药性对于改善黑色素瘤患者生存率至关重要.
- 对抗药性机制的进一步研究将指导开发更有效的治疗方法.
- 更深入地了解耐药性对于设计下一代黑色素瘤疗法至关重要.
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

